P (RCC) was first done in the late 1930s and reported in
|
|
- Lee Barrett
- 6 years ago
- Views:
Transcription
1 Pulmonry Resection of Metsttic Renl Cell Crcinom Robert J. Cerfolio, MD, Mrk S. Allen, MD, Clude Deschmps, MD, Richrd C. Dly, MD, Steven L. Wllrichs, BS, Victor F. Trstek, MD, nd Peter C. Pirolero, MD Sections of Generl Thorcic Surgery nd Biosttistics, Myo Clinic nd Myo Foundtion, Rochester, Minnesot Between 965 nd 989, 96 consecutive ptients (64 men nd 32 women) underwent complete pulmonry resection for metsttic renl cell crcinom. Medin ge ws 63 yers (rnge, 33 to 82 yers). Medin time between nephrectomy nd pulmonry resection ws 3.4 yers (rnge, 0 to 8.4 yers). Forty-eight ptients hd solitry metstsis, 6 hd two, 8 hd three, nd 4 hd more thn three. Wedge excision ws performed in 62 ptients, segmentectomy in 3, lobectomy in 25, bilobectomy in 3, nd pneumonectomy in 3. Fourteen ptients hd repet thorcotomy for recurrent metstsis; 34 other ptients lso hd complete resection of limited extrpulmonry disese. There were no opertive deths. Medin follow-up ws 3 yers (rnge, 70 dys to 9.0 yers). Overll 5-yer survivl ws 35.9%. Ptients with solitry metstsis hd 5-yer survivl of 45.6% compred with 27.0% for ptients with multiple metstses (p < 0.05). Ptients with tumor-free intervl greter thn the medin of 3.4 yers hd better survivl (p = 0.05) thn those with tumor-free intervl less thn or equl to 3.4 yers. Fiveyer survivl for ptients who underwent repet thorcotomy or hd complete resection of extrpulmonry disese did not differ from overll survivl. We conclude tht resection of renl lung metstsis is sfe nd effective, tht ptients with solitry metstsis hve better survivl thn those with multiple metstses, tht resectble extrpulmonry disese does not necessrily contrindicte pulmonry resection, nd tht repet thorcotomy is wrrnted in selected ptients with recurrent lung metstses. (Ann Thorc Surg 994;57:33944) ulmonry resection of metsttic renl cell crcinom P (RCC) ws first done in the lte 930s nd reported in 938 by Brney nd Churchill [l]. They performed this procedure on 55-yer-old womn who subsequently survived for 23 yers. Since then, mny ptients hve undergone similr procedures. Yet, pulmonry resection remins controversil, nd the fctors tht determine long-term survivl re not completely understood. Most series re limited by smll numbers of ptients. Few reports hve ddressed the role of repet thorcotomy for recurrent cncer nd the role of pulmonry resection in the presence of limited extrpulmonry disese. The purpose of this review ws to nlyze our experience with pulmonry resection for metsttic RCC nd to identify those fctors ssocited with prolonged survivl. Mteril nd Methods Between Jnury, 965, nd December 3, 989, 47 consecutive ptients underwent thorcotomy for metsttic RCC t our institution. Ninety-six ptients underwent complete resection. Resection ws considered complete if ll known pulmonry cncer ws removed t thorcotomy. The remining 5 ptients who hd pulmo- Presented t the Twenty-ninth Annul Meeting of The Society of Thorcic Surgeons, Sn Antonio, TX, Jn 25-27, 993. Address reprint requests to Dr Allen, Myo Clinic, 0 First St SW, Rochester, MN nry biopsy only or incomplete resections were excluded from further nlysis. Only ptients tht hd cler cell renl crcinom were included. Ptients who hd complete resections of ll known extrpulmonry disese were lso included. The records of ll 96 ptients were reviewed for ge nd sex, dimeter, grde, TNM clssifiction, nd mngement of the primry RCC; tumor-free intervl; loction, dimeter, grde, nd number of pulmonry metstses; number nd extent of pulmonry resection, complictions, nd long-term survivl. All RCCs were stged postsurgiclly by the TNM clssifiction system of the Americn Joint Committee for Cncer Stging nd End Results Reporting (Tble ) [2]. Opertive mortlity included ptients who died within 30 dys fter thorcotomy or those who died lter but during the sme hospitliztion. Survivl ws estimted by the Kpln-Meier method using the dte of pulmonry resection s the strting point [3]. The influence of vribles on survivl ws nlyzed using the log-rnk test for discrete vribles [4] nd the proportionl hzrds model of Cox for continuous vribles [5]. Vlues of p less thn 0.05 were considered sttisticlly significnt. Clinicl Findings The medin ge of the 96 ptients (64 men nd 32 women) ws 63 yers (rnge, 3 to 82 yers) t the time of their first thorcotomy. The RCC ws locted in the right kidney in 40 ptients nd in the left in 56. A rdicl nephrectomy ws performed in 93 ptients, rdicl nephrectomy plus by The Society of Thorcic Surgeons /94/$7.00
2 340 CERFOLIO ET AL Ann Thorc Surg 994;5733% Tble. RCC Stging System-TNM Clssifiction T T2 T3 T3b T3c T4 NO N N2 N3 MO M Stge I Stge I Stge Stge IV Clssifiction Description Any size, no renl distortion Renl distortion Invdes perinephric tissue (ft), through cpsule Invdes renl vein Invdes renl vein nd infrdiphrgmtic inferior ven cv Invdes djcent structures No nodes involved with tumor Single node involved Multiple regionl nodes involved Fixed nodes No metsttic nodules Metsttic lesions T NO MO, T2 NO MO T3 NO MO T3b NO MO, T3c NO MO, ny T with N-3 T4 NO MO, ny T or N with M tumor thrombus excision in 2 ptients, nd heminephrectomy in ptient. The tumor ws grde in 6 ptients, grde 2 in 57, grde 3 in 2, nd grde 4 in 2 ptients. Medin tumor dimeter ws 8.0 cm (rnge, 2.5 to 8.0 cm). The neoplsm ws postsurgiclly clssified s stge I in 36 ptients, stge I in 34, stge I in 2, nd stge IV in 5 ptients. Ten ptients hd T renl tumors, 27 hd T2, 35 hd T3, hd T3b, 3 hd T3c, nd ptient hd T4. Lymph nodes were clssified s NO in 94 ptients nd either N or N2 in ptient ech. Distnt metstses were bsent in 92 ptients (MO); the remining 4 ptients ll hd pulmonry metstsis (Ml). Sixty-eight ptients hd no djuvnt tretment fter pulmonry resection; 3 hd rdition, 7 hd chemotherpy, 5 hd immunotherpy, nd 3 hd vrious combintions. Pulmonry metstses were symptomtic in 85 ptients (88.5%). Symptoms in the remining ll ptients included hemoptysis in 6, cough in 3, pin in, nd cough nd pin in. Computed tomogrphy (CT) ws vilble during the ltter time period of this study nd ws performed in 72 ptients. CT predicted the correct number of metsttic nodules in 5 of the 72 utients (70.8%). In 2 ptients (29.2%), 79 dditionl metsttic nodules were found t thorcotomy (Tble 2). All ptients were evluted preopertively for locl recurrence of their RCC. Abdominl CT ws the proce- Tble 2. Accurcy of Computed Tomogrphy in Finding Pulmonry Nodules Number of Metstses Number of CT Accurcy Predicted by CT Ptients ("/.I Multiple 4 00 CT = computed tomogrphy. dure most commonly performed. Bone nd brin or liver scns were performed if clinicl or lbortory findings suggested metstses in these res. All pulmonry resections were performed t our institution. Pulmonry resection followed nephrectomy in 92 ptients. No ptient hd spontneous regression of their pulmonry metstsis fter nephrectomy. Four ptients hd concomitnt pulmonry resection nd nephrectomy. The medin intervl between nephrectomy nd the dignosis of pulmonry metstsis ws 3.4 yers (rnge, 0 to 8.4 yers). Lterl thorcotomy ws performed in 92 ptients nd medin sternotomy in 4 ptients. No ptient underwent stged or simultneous bilterl thorcotomies. Fifty-three ptients hd wedge excisions; 23 of these were multiple. A lobectomy ws performed in 25 ptients, pneumonectomy in 3, segmentectomy in 3, nd bilobectomy in 3. Another 6 ptients hd wedge excision combined with lobectomy nd 3 ptients hd wedge excision combined with segmentectomy. At opertion, pulmonry metstses were unilterl in 92 ptients (52 right nd 40 left) nd bilterl in 4 ptients. Two hundred thirty-nine metstses were resected in these 96 ptients (Fig ). Forty-eight ptients (50%) hd solitry pulmonry metstsis, 6 hd two, 8 hd three, 4 hd four, 3 hd five, 2 hd six, 2 hd seven, hd eight, hd 7, nd hd 23. The medin dimeter of the pulmonry metstses ws 2.0 cm (rnge, 0.5 to 7.0 cm). Six ptients lso hd RCC in intrpulmonry lymph nodes (Nl), 4 ptients by direct extension nd 2 by metstsis. Five other ptients hd metstses to N2 lymph nodes nd ptient to N3 lymph node. The metsttic pulmonry lesions were Broders' grde in 7 ptients, grde 2 in 55, grde 3 in 28, nd grde 4 in 6. Eleven ptients hd second thorcotomy, nd 3 of these ptients hd third thorcotomy. Eight ptients underwent reopertion on the ipsilterl thorx. The medin intervl between the first nd second thorcotomy ws 4 months (rnge, month to 0 yers); the intervl between the second nd third thorcotomy ws 3 months, 57 months, nd 2 yers. Eleven reopertions were wedge excision only; the remining three were segmentectomy, lobectomy, nd pneumonectomy in ptient ech. Thirty-four ptients hd resection of limited extrpul- Fig I. Locution of the 239 renl cell metstses.
3 Ann Thorc Surg 994; CERFOLIO ET AL 34 monry disese. All ptients hd solitry metstsis tht were locted in the bone in, brin in 0, bdominl cvity in 8, sclp in 2, nd thyroid, pncres, nd neck in ptient ech. Four ptients hd extrpulmonry disese resected from 6 months to 3 yers before pulmonry resection; the remining 30 ptients hd their extrpulmonry disese resected up to 2 months fter thorcotomy. Seven of the ltter 30 ptients hd extrpulmonry metstsis discovered t the sme time s pulmonry metstsis. Results Complictions occurred in 9 ptients nd included tril fibrilltion in 6 (6.3%), pneumoni in 2 (2.%), nd prolonged ir lek (4 dys) in ptient (%). There were no opertive deths. Follow-up ws complete in ll ptients nd rnged from 70 dys to 9 yers (medin, 3.0 yers). Metsttic RCC recurred in 52 ptients (54.2%)(Tble 3). Recurrence ws to multiple orgn systems in 7 ptients nd involved the lungs in 6 ptients. In 2 other ptients, recurrence ws limited to the lungs. Altogether, recurrence fter pulmonry resection involved the lungs in 8 ptients (34.6%). Twenty-two ptients re currently live, none with evidence of cncer. Seventy-four ptients re ded, 52 from recurrent RCC. Overll estimted 5-yer survivl ws 35.7% (Fig 2) nd did not differ for the three decdes of this study. Survivl ws not influenced by ge, sex, RCC TNM clssifiction, pulmonry signs nd symptoms, loction or dimeter of the pulmonry metstses, or extent of pulmonry resection. Only the number of pulmonry metstses nd tumor-free intervl influenced survivl. Five-yer survivl for ptients with solitry metstsis ws 45.6% compred with 27.0% (Fig 3) for ptients with multiple metstses (p < 0.05). Similrly, 5-yer survivl for ptients with tumor-free intervl more thn 3.4 yers ws 45.4% compred with 26.0% (Fig 4) for ptients less thn or equl to 3.4 yers (p < 0.0). The 62 ptients who underwent wedge excision only hd 5-yer survivl of 3.7% (medin, 3.7 yers) s compred with 42.8% (medin, 4.2 yers) for the 34 ptients who hd either pneu- Tble 3. Loction of Recurrence Loction Bone Lung Brin AbdomenAiver Crcinomtosis Lung nd bone Lung nd brin Lung nd ribs Brin nd bones Adrenl Pncres Thyroid Extremity No. of Ptients Fig 2. Overll probbility of survivl (deth from ny cuse) of the 96 ptients undergoing curtive pulmon y resection of cler cell renl crcinom metsttic to the lung. Zero time on the bsciss represents the dte of pulmonry resection. monectomy, lobectomy, or segmentectomy (p = not significnt). The 5 ptients who hd pulmonry biopsy only or incomplete resection hd 5-yer survivl of only 6.7% (medin, 5 months). Survivl of the 34 ptients who hd extrpulmonry disese resected did not differ significntly from the 62 ptients without extrpulmonry disese (Fig 5). The 30 ptients who hd extrpulmonry disese resected fter thorcotomy hd 5-yer survivl of 37.5%; however, none of the 4 ptients tht hd their extrpulmonry disese resected before thorcotomy survived longer thn 3 yers 7 months. Five-yer survivl for the ptients from the dte of their second thorcotomy ws 30.8% nd did not differ significntly from the 33.3% survivl observed for the 85 ptients who hd only one thorcotomy (Fig 6). Two of the 3 ptients who underwent third thorcotomy died 6 nd 8 yers fter their lst resection of other cuses. The 00 ru.- > $ 60 rn c K Q) 40 $2 (I) Solitry - 2 TWO P c \ Fig 3. Probbility of survivl (deth from ny cuse) of the 48 ptients undergoing curtive pulmon y resection of solit y renl cell crcinom metsttic to the lung s compred with 48 ptients with multiple pulmonry metstses (p < 0.05). Zero time on the bsciss represents the dte of pulmonry resection.
4 342 CERFOLIO ET AL Ann Thorc Surg 994;57: > 5 60 fn Y C 8 40 t 0 \ > 3.4 yrs \ \ - I 3.4 yrs ** P c 0.0 \ ', I I I I I I l l I II Fig 4. Probbility of survivl (deth from ny cuse) of the 48 ptients undergoing curtive pulmon y resection of renl cell crcinom metsttic to the lung with tumor-free intervl of less thn or equl to 3.4 yers s compred with 48 ptients with tumor-free intervl of greter thn 3.4 yers (p < 0.0). Zero time on the bsciss represents the dte of pulmonry resection. remining ptient is live without recurrence 3 yers fter the third thorcotomy. Comment Ech yer in the United Sttes RCC develops in pproximtely 25,000 ptients, nd this represents pproximtely 3% of ll dult mlignncies [6]. Twenty-five to 30% of these ptients hve metstses t the time the RCC is dignosed, nd 30% to 50% will develop pulmonry metstses lter [7, 8. The 5-yer survivl of ptients with unresected metsttic RCC is only 2.7% [9]. Chemotherpy, rdition therpy, nd immunotherpy hve not been proven to be effective tretment for metsttic disese [lo-5, nd surgery remins the only effective tretment for ptients with limited metsttic RCC. Evlution of ptients with history of RCC who present with pulmonry nodule should include history nd physicl exmintion. RCC cn metstsize to unusul loctions such s the pncres, thyroid, gllbldder, iris, nd epididymis [6]; thus, the preopertive evlution should be thorough. Old chest roentgenogrms should be exmined to determine if the nodule ws present in the pst. Chest CT should be obtined to serch for dditionl pulmonry nodules or medistinl denopthy. The CT should lso include the liver, drenls, nd bed of the resected kidney to exclude bdominl recurrence. If no evidence of bdominl recurrence is found nd the ptient is n cceptble surgicl risk, the pulmonry nodule should be resected. We fvor lterl thorcotomy for unilterl disese nd medin sternotomy for bilterl disese. At opertion, the lung should be plpted crefully nd ll nodules locted before beginning resection. Enlrged lymph nodes should be resected. Although thorcoscopy hs been used recently to resect metsttic nodules [7], we believe tht this is n indequte curtive tretment. Becuse thorcoscopy does not llow dequte plption of the remining lung, nodules not visulized on CT will remin undetected. Our dt indicte tht pproximtely onethird of the ptients hd dditionl nodules resected t thorcotomy tht were not detected by CT. We hve reported similr findings for colorectl pulmonry metstses [ 8. Thus, thorcoscopy lone would probbly result in lower 5-yer survivl. Consequently, thorcoscopic resection of metsttic nodules should be limited to dignosis only. Resection cn usully be ccomplished by wedge excision. Occsionlly, it is necessry to perform segmentectomy, lobectomy, or even pneumonectomy. In our series, ptients who hd more extensive resection tended to hve better survivl, lthough not sttisticlly significnt. In ptients with bilterl metstses, complete resection cn often be ccomplished by medin sternot $60 fn CI c 8 40 t v) c C 8 40 t ---- Single - Multiple Fig 5. Probbility of survivl (deth from ny cuse) of the 62 ptients undergoing curtive pulmon y resection of renl cell crcinom metsttic to the lung without extrpulmon y disese s compred with 34 ptients with limited extrpulmony disese (p = not significnt). Zero time on the bsciss represents the dte of pulmonry resection. n Fig 6. Probbility of survivl (deth from ny cuse) of 82 ptients undergoing single thorcotomy for renl cell crcinom metsttic to the lung s compred with 4 ptients who underwent multiple thorcotomies for recurrent renl cell crcinom to the lungs. Zero time on the bsciss represents the dte of the lst thorcotomy.
5 Ann Thorc Surg 994: CERFOLIO ET AL 343 omy. However, if the lesions re locted posteriorly in the left lower lobe, bilterl stged thorcotomies my be preferble lterntive. Differentiting RCC pulmonry metstsis from primry lung cncer cn be difficult t times. Lymph node involvement from hemtogenous metstsis to the lungs is unusul. In the present series, only 2 ptients hd lymph node metstses. Consequently, if extensive lymph node metstses re present, the pulmonry nodule my be primry lung cncer rther thn n RCC metstsis. If the lesion cnnot be differentited from primry lung cncer t the time of opertion, the lesion should be mnged s lung cncer with lobectomy nd medistinl node dissection. In our series, ptients with solitry pulmonry nodule hd 5-yer survivl of 45.6%. Although the survivl of ptients with multiple pulmonry metstses ws significntly less (27.0%), it ws better thn the nturl history of unresected metsttic disese. Thus, pulmonry resection is wrrnted for selected ptients with multiple pulmonry metsttic nodules, including ptients with bilterl nodules. However, when CT revels numerous nodules, resection is less likely to be beneficil. An erlier study from our institution demonstrted 5-yer survivl of 27% [9]. Our present survivl of 35.7% is slightly better becuse ptients who hd incomplete resection were excluded. Our previous study demonstrted tht both disese-free intervl nd the dimeter of the lrgest nodule resected ffected survivl. In the present study, the dimeter of the lrgest nodule resected ws not significnt predictor of survivl. The erlier study my hve reched different conclusion becuse of the smller number of ptients involved. Other uthors hve reported vrying dt. Tobisu nd collegues [] in 990, nd Pogrebnik nd co-workers [2] in 99, demonstrted no difference in survivl mong ptients with single versus multiple pulmonry metstses. However, Ktzenstein nd collegues [22] in 978, nd our present study demonstrted tht ptients with multiple metstses hd lower 5-yer survivl. These differences my be ttributble to the lrger number of ptients in our series. Usul criteri for resectbility in ptients with pulmonry metstsis is the bsence of extrpulmonry disese. However, our 5-yer survivl of ptients who hd limited extrpulmonry disese resected ws similr to tht observed for ptients without extrpulmonry metstsis. We hve reported similr findings for colorectl pulmonry metstses [8]. Although ptients with limited extrpulmonry disese represent selected popultion, combined pulmonry nd extrpulmonry resection ppers to offer resonble chnce for cure, nd we continue to recommend resection in these ptients. Close surveillnce is necessry to detect recurrent disese. We recommend binnul chest roentgenogrm nd chest CT. Follow-up must be lifelong becuse recurrent pulmonry metstses developed s long s 0 yers fter the first thorcotomy nd 2 yers fter the second. Fourteen ptients hd repet thorcotomy. Their 5-yer survivl ws similr to tht observed for our ptients with single thorcotomy. Importntly, ptients undergoing repet thorcotomy hd no increse in either morbidity or mortlity. Moreover, ll of our ptients who underwent third thorcotomy were live t lest 5 yers fter the first resection. Hence, we continue to recommend repet thorcotomies for recurrent metsttic RCC in selected ptients. We conclude tht pulmonry resection of metsttic renl cell crcinom is sfe nd effective, tht ptients with solitry metstsis hve better survivl thn those with multiple metstses, tht resectble extrpulmonry disese does not necessrily contrindicte pulmonry resection, nd tht repet thorcotomy is wrrnted in selected ptients with recurrent lung metstses. References. Brney JD, Churchill EJ. Adenocrcinom of the kidney with metstsis to the lung. J Urol 939;42: Behrs OH, Myers MH (eds). Americn Joint Commission on Cncer: Mnul for stging of cncer, 2nd ed. Phildelphi: Lippincott, 983: Kpln EL, Meier P. Non-prmetric estimtion from incomplete observtions. J Am Stt Assoc 958;53:457-&. 4. Pet0 R, Pet0 J. Asymptoticlly efficient rnk nd invrint procedures. J R Sttist SOC, Series A 972;35: Cox DR. Regression models nd life-tble (with discussion). J R Sttist SOC, Series B 972;34: Boring CC, Squires TS, Tong T. Cncer sttistics, 99. Cncer 99;4:% Dekernion JB, Rmming KP. The nturl history of metsttic renl cell crcinom: computer nlysis. J Urol 978; : Ptel NP, Lvenwook RW. Renl cell cncer: history nd results of tretment. J Urol 978;9: Riches E. The nturl history of renl tumors. In: Tumors of the kidney nd ureter. Edinburgh: Churchill Livingstone, 984: Poster DS, Bruno S, Pent JS. Current sttus of chemotherpy, hormonl therpy, nd immunotherpy in the tret- ment of renl cell crcinom. Am J Clin Oncol 982;5:5?-60.. Luderer RC, Opipri ML, Perrott AL. Tretment of metsttic renl cell crcinom: review of experience nd world literture. J Am Oncol Assoc 978;7759M Rosenberg SA, Lotze MT, Moul LM. A progress report on the tretment of 57 ptients with dvnced cncer using lymphokine ctivted killer cells nd interleukin-2. N Engl J Med 987;36: Thompson JA, Lee DJ, Cox W. Recombinnt interleukin-2 toxicity, phrmcokinetics, nd immunotherpy effects in phse I tril. Cncer Res 987;47: Bukowski RM, Osgood 8, Sergi J. Phse INIB tril of interleukin-2 nd interferon-2. Results in metsttic renl cell cncer. J Urol 988;39:283A. 5. Rosenberg SA, Lotze MT, Yng JC. Experience with use of high dose interleukin-2 in tretment of 652 cncer ptients. Ann Surg 989;:47p Tbr WS, Mchio AM, Aftimus GP. Metsttic renl cell crcinom-renl tumors. Proceedings of First Interntionl Symposium on Kidney Tumors. New York Liss, Dowling RD, Ferson PF, Lndreneu RJ. Thorcoscopic resection of pulmonry metstses. Chest 992;02:45&4. 8. McAfee MK, Allen MS, Trstek VF, et l. Colorectl lung metstses: results of surgicl excision. Ann Thorc Surg 992;53:78M. 9. Jett JR, Hollinger CG, Zinsmiester AR, Pirolero PC. Pulmonry resection of metsttic renl cell crcinom. Chest 983;84: Tobisu K, Kkigie T. Surgicl tretment of metsttic renl cell crcinom. Jpn J Clin Oncol 990;:263-7.
6 344 CERFOLIO ET AL Ann Thorc Surg 994; Pogrebnik HW, Hs G, Linehn WM, Rosenberg SA, Pss HI. Renl cell crcinom: resection of solitry nd multiple metstses. Ann Thorc Surg 992;54: Ktzenstein AL, Purvis R Jr, Gmelich J, Askin F. Pulmonry resection for metsttic renl denocrcinom. Cncer 978; 4 : DISCUSSION DR JACK A. ROTH (Houston, TX): I believe this report represents n importnt contribution. Resection of isolted pulmonry metstses is n ccepted tretment modlity, nd it remins ccepted despite the complete bsence of prospective clinicl trils definitively documenting efficcy. This cceptnce is bsed on the retrospective review of cses tht document long-term survivl in ptients such s the ones tht hve just been presented who do not hve ny other curtive tretments vilble. Survivl t 5 yers for some groups of ptients with isolted pulmonry metstses fter resection is superior to the overll survivl of ptients with primry lung cncer. Nevertheless, mny ptients do not pper to benefit from resection of their metstses, nd it would be extremely helpful to the surgeon to be ble to select in dvnce those ptients for whom resection offered high probbility of fvorble outcome. The report by Dr Cerfolio nd his collegues provides help by identifying some of these prognostic fctors. However, I think severl cvets should be mentioned. The prognostic fctors they identify re not sufficiently precise to be used to exclude ptients from surgery. In their study, ptients with multiple metstses still hd 27% 5-yer survivl, lthough this ws lower thn the group hving solitry metstsis. It my not be pproprite to exclude ptients with dverse prognostic fctors from surgicl resection if there re no other potentilly curtive tretment options nd if the morbidity of the surgery is felt to be low. Ptients with isolted pulmonry metstses re very heterogeneous group. For exmple, it is not possible to extrpolte dt on prognostic fctors from ptients with dult soft tissue srcoms to ptients with other tumor histologies. Prognostic fctors, such s the number of metstses resected nd tumor doubling time, my be predictive for srcom ptients but not for other types of histologies. For osteogenic srcom nd soft tissue srcom the number of metstses resected, three or fewer, ws predictive of improved survivl. Tumor doubling time ws predictive for soft tissue srcoms, but not for osteogenic srcom. For brest nd melnom, these predictive fctors my not lwys pply. I would like to point out the very heterogeneous survivl rtes t 5 yers for these vrious histologies. Our experience t M.D. Anderson with respect to reopertion for srcom ptients does gree with the Myo Clinic experience for reopertion for hypernephrom. Although these groups re not completely comprble, I think this does point out tht n ggressive surgicl pproch to these ptients cn be beneficil. For exmple, here re three groups of ptients hving only one, two, or three resections of dult soft tissue srcoms. The medin survivl is essentilly identicl for ll three groups tht hd resections. I hve severl questions for Dr Cerfolio nd ssocites. Wht criteri did you use to distinguish between metstsis nd secondry primry cncer in ptients with solitry lung lesion? Some of your ptients hd very prolonged disese-free intervl, suggesting second primry lesion. Do you give djuvnt therpy before or fter resection of the metstses, nd if so, wht is the proper timing for surgery? Hypernephrom is quite responsive to some types of biologic therpy such s interleukin-2 or interferon. There were 3 ptients in your series tht hd pneumonectomy. Wht do you feel re the pproprite indictions for pneumonectomy for metsttic hypernephrom, nd wht ws the outcome for these ptients? I congrtulte Dr Cerfolio nd ssocites on their excellent presenttion nd thnk The Society for the privilege of discussing this report. DR BENEDICT D. T. DALY (Boston, MA): We enjoyed this report very much. I noted tht the series ended in 989, which prompts two or three comments nd question. Since 988 we hve operted on number of ptients with metsttic hypernephrom fter interleukin-2 therpy. Ptients with metstses limited to the lung hve in generl fllen into two groups. In the ptients with single nodules tht hve remined stble fter interleukin-2 therpy we hve undertken resection for cure. The other group of ptients re those who hve multiple pulmonry nodules nd no evidence of disese elsewherethese we hve tended to follow. Over the course of time most of the nodules in this group will remin stble, but one or two of the nodules my increse in size. In these ptients we hve resected the enlrging nodule nd ll of the other nodules in the ipsilterl chest. The enlrging nodules hve invribly contined cncer, the stble nodules in mny cses hve been inflmmtory, nd in other cses hve contined cncer. The third observtion we hve mde is tht when operting on these ptients in proximity to interleukin-2 therpy nd by tht I men within the first 4 to 6 months, there cn be enlrged hilr nodes with n intense perivsculr rection secondry to perinodl inflmmtion, mking resection difficult. I would like to sk the uthors if they hve hd ny experience in resecting hypernephrom in ptients fter interleukin-2 therpy nd if so, hve they estblished ny guidelines for mngement. DR CERFOLIO: Thnk you, Drs Roth nd Dily for your comments. To nswer Dr Roths questions first, we gree tht the prognostic fctors tht we identified re not precise, nd they, by themselves, should not preclude pulmonry resection. Deciding if lung neoplsm is primry cncer versus metstsis cn be difficult. In this study pulmonry neoplsm ws considered metstsis if the histologic fetures were similr to the originl primry cncer. Cliniclly, if there is ny equivoclity s to the histologicl nture of pulmonry nodule, the lesion should be treted s primry lung cncer. One of your questions, Dr Roth, ddressed djunctive tretment. We did hve 3 ptients who were treted with interleukin-2, but s Dr Dly mentioned, the dt were preliminry. Most of our ptients received different doses nd different schedules tht re currently being recommended. Therefore, we cn mke no conclusions s to the vlue of preopertive interleukin-2. Doctor Roths lst question ws the criteri for pneumonectomy. In generl, the number of pulmonry metstses did not dictte this procedure; rther the extent of centrl disese ws more importnt. Of course, good pulmonry function ws mndtory. Doctor Dly, I believe I hve lredy nswered your question bout interleukin-2.
Efficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationImpact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors
Originl Article Impct of Positive Nodl Metstses in Ptients with Thymic Crcinom nd Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, nd Jennifer L. Sullivn, MD Introduction: Thymic crcinoms
More informationLung cancer is the leading cause of cancer death worldwide, EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Originl Article EGFR Muttion nd Brin Metstsis in Pulmonry Adenocrcinoms Dong-Yeop Shin, MD,* Im Il N, MD,* Cheol Hyeon Kim, MD, PhD, Sunhoo Prk, MD, PhD, HeeJong Bek, MD, PhD, nd Sung Hyun Yng, MD, PhD*
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationBENIGN ulceration along the greater curvature of the pars media of the
BENIGN ULCERS OF THE GREATER CURVATURE OF THE STOMACH Report of Two Cses CHARLES H. BROWN, M.D. Deprtment of Gstroenterology nd ANTHONY D. INTRIERE, M.D.* BENIGN ulcertion long the greter curvture of the
More informationFertility in Norwegian testicular cancer patients
DOI: 0.054/ bjoc.999.0989, vilble online t http://www.idelibrry.com on Fertility in Norwegin testiculr cncer ptients SD Fosså nd Ø Krvdl 2 The Norwegin Rdium Hospitl, Montebello, N-030 Oslo, Norwy; 2 The
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationRelation of Tumor Size, Lymph Node Status, and Survival in
Reltion of Tumor Size, Lymph Node Sttus, nd Survivl in 24,74 Brest Cncer Cses CHRISTINE L. CARTER, PHD, MPH,* CAROL ALLEN, PHD,t AND DONALD E. HENSON, MD* Two of the most importnt prognostic indictors
More informationClinical manifestations in patients with alpha-fetoprotein producing gastric cancer
Curr Oncol, Vol. 21, pp. e394-399; doi: http://dx.doi.org/10.3747/co.21.1768 CLINICAL MANIFESTATIONS IN AFP PRODUCING GASTRIC CANCER ORIGINAL ARTICLE Clinicl mnifesttions in ptients with lph-fetoprotein
More informationLung cancer is the leading cause of cancer-related deaths in
ORIGINAL ARTICLE Resection Rte nd Outcome of Pulmonry Resections for Non Smll-Cell Lung Cncer A Ntionwide Study From Icelnd Hunbogi Thorsteinsson, MD,* Asgeir Alexndersson, MD,* Gudrun N. Oskrsdottir,
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationEsophageal carcinoma is the eighth most common cancer
ORIGINAL ARTICLE Tumor-Strom Rtio Is n Independent Predictor for Survivl in Esophgel Squmous Cell Crcinom Ki Wng, MD,* Wei M, MD,* Jinbo Wng, MD,* Ling Yu, MD, Xiomei Zhng, MD, Zhenbo Wng, MD, Bingxu Tn,
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationNatural History and Treatment of Wilms's Tumour : An Analysis of 335 Cases Occurring in England and Wales
24 October MEDCL JOURNL 15 Ppers nd Originls Nturl History nd Tretment Wilms's Tumour : n nlysis 335 Cses Occurring in Englnd nd Wles 12- E. M. LEDLE,* M.B., B.S., D.M.R.; L. S. MYNORS,* M.B., B.S.; G.
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationAge related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer
MOLECULAR AND CLINICAL ONCOLOGY 9: 329-334, 2018 Age relted differences in prognosis nd prognostic fctors mong ptients with epithelil ovrin cncer KENJI YOSHIKAWA, TAKESHI FUKUDA, RYO UEMURA, HIROAKI MATSUBARA,
More informationAmerican Joint Committee on Cancer Staging and Clinicopathological High-Risk Predictors of Ocular Surface Squamous Neoplasia
Americn Joint Committee on Cncer Stging nd Clinicopthologicl High-Risk Predictors of Oculr Surfce Squmous Neoplsi A Study From Tertiry Eye Center in Indi Sheetl Chuhn, MSc; Seem Sen, MD; Anjn Shrm, PhD;
More informationPatient Survival After Surgical Treatment of Rectal Cancer
Originl Article Ptient Survivl After Surgicl Tretment of Rectl Cncer Impct of Surgeon nd Hospitl Chrcteristics Dvid A. Etzioni, MD, MSHS 1,2 ; Toni M. Young-Fdok, MD, MS 1 ; Robert R. Cim, MD, MA 2,3 ;
More informationPrognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic
Crcinogenesis, 2015, Vol. 36, No. 2, 243 248 doi:10.1093/crcin/bgu247 Advnce Access publiction December 18, 2014 Originl Mnuscript originl mnuscript Prognostic significnce of pretretment serum levels of
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationEmerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data
Emerging Options for Thromboprophylxis After Orthopedic Surgery: A Review of Clinicl Dt Bob L. Lobo, Phrm.D. In four rndomized, controlled studies of ptients undergoing orthopedic surgery, the ntithrombotic
More informationThe Role of Intraoperative Radiation Therapy (IORT) in the Treatment of Locally Advanced Gynecologic Malignancies
The Role of Intropertive Rdition Therpy (IORT) in the Tretment of Loclly Advnced Gynecologic Mlignncies MARCELA G. DEL CARMEN, JAMES F. MCINTYRE, b ANNEKATHRYN GOODMAN Vincent Gynecologic Oncology Service,
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationCompletion pneumonectomy (CP) refers to the complete
ORIGINAL ARTICLE Completion Pneumonectomy in Ptients with Cncer Postopertive Survivl nd Mortlity Fctors Myeul Tbutin, MD, MSc,* Sébstien Courud, MD, MSc, Benoit Guibert, MD, Pierre Mulsnt, MD, Pierre-Jen
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationOriginal Article. Breast Care 2016;11: DOI: /
Originl Article Brest Cre 2016;11:323 327 DOI: 10.1159/000452079 Published online: October 24, 2016 Neodjuvnt Chemotherpy with Docetxel, Crbopltin nd Weekly Trstuzumb Is Active in HER2-Positive Erly Brest
More informationAsian Journal of Andrology (2017) 19,
(2017) 19, 20 25 2017 AJA, SIMM & SJTU. All rights reserved 1008-682X www.sindro.com; www.jndrology.com Prostte Cncer Open Access ORIGINAL ARTICLE Refining the Americn Urologicl Assocition nd Americn Society
More informationORIGINAL ARTICLE. Diagnostic Signs of Accommodative Insufficiency. PILAR CACHO, OD, ÁNGEL GARCÍA, OD, FRANCISCO LARA, OD, and M A MAR SEGUÍ, OD
1040-5488/02/7909-0614/0 VOL. 79, NO. 9, PP. 614 620 OPTOMETRY AND VISION SCIENCE Copyright 2002 Americn Acdemy of Optometry ORIGINAL ARTICLE Dignostic Signs of Accommodtive Insufficiency PILAR CACHO,
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationProphylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications
Gstric Cncer (2018) 21:703 709 https://doi.org/10.1007/s10120-017-0781-y ORIGINAL ARTICLE Prophylctic effect of neodjuvnt chemotherpy in gstric cncer ptients with postopertive complictions Kojiro Eto 1
More informationMOLECULAR AND CLINICAL ONCOLOGY 5: , 2016
MOLECULAR AND CLINICAL ONCOLOGY 5: 429-436, 2016 Improvement of survivl with postmstectomy rdiotherpy in ptients with 1-3 positive xillry lymph nodes: A systemtic review nd met-nlysis of the current literture
More informationWSU Tree Fruit Research and Extension Center, Wenatchee (509) ext. 265;
FINAL REPORT WTFRC Project # AH-1-5 WSU Project # 13C-355-3 Project title: PI: Orgniztion: Coopertors: of Sunburn in Apples with RAYNOX Lrry Schrder, Horticulturist WSU Tree Fruit Reserch nd Extension
More informationAdjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice
doi: 10.1054/ bjoc.2001.2035, vilble online t http://www.idelibrry.com on http://www.bjcncer.com Adjuvnt chemotherpy for colon crcinom with positive lymph nodes: use nd benefit in routine helth cre prctice
More informationImproved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study
Journl of Heptology 37 (2002) 78 86 www.elsevier.com/locte/jhep Improved prognosis of postopertive heptocellulr crcinom ptients when treted with functionl foods: prospective cohort study Yoichi Mtsui*,
More informationClassic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features
The Koren Journl of Pthology 2014; 48: 201-208 ORIGINAL ARTICLE Clssic Ppillry Thyroid Crcinom with Tll Cell Fetures nd Tll Cell Vrint Hve Similr Clinicopthologic Fetures Woo Jin Oh 1 Young Sub Lee 1 Uiju
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationBreast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study
Originl Article Brest Cre 2017;12:29 33 DOI: 10.1159/000455003 Published online: Februry 8, 2017 Brest-Conserving Surgery Under Locl in Elderly Ptients with Severe Crdiorespirtory Comorbidities: A Hospitl-Bsed
More informationCase Report INTRODUCTION CASE REPORT. pissn eissn X
pissn 2287-2728 eissn 2287-285X Cse Report Clinicl nd Moleculr Heptology 2018;24:424-429 Complete cure of dvnced heptocellulr crcinom with right drenl glnd metstsis nd portl vein thrombosis by multiple
More informationDA XU *, XIAOFENG LIU *, LIJUN WANG and BAOCAI XING
ONCOLOGY LETTERS Heptectomy plus djuvnt trnsctheter rteril chemoemboliztion improves the survivl rte of ptients with multicentric occurrence of heptocellulr crcinom DA XU *, XIAOFENG LIU *, LIJUN WANG
More information2. Hubs and authorities, a more detailed evaluation of the importance of Web pages using a variant of
5 Web Serch Outline: 1. Pge rnk, for discovering the most ëimportnt" pges on the Web, s used in Google. 2. Hubs nd uthorities, more detiled evlution of the importnce of Web pges using vrint of the eigenvector
More informationThe potential future of targeted radionuclide therapy: implications for occupational exposure? P. Covens
The potentil future of trgeted rdionuclide therpy: implictions for occuptionl exposure? Introduction: Trgeted Rdionuclide Therpy (TRT) Systemic tretment Molecule lbelled with rdionuclide delivers toxic
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationPerforation Following Colorectal Endoscopy: What Happens Beyond the Endoscopy Suite?
credits vilble for this rticle see pge 88. Originl RESEARCH & CONTRIBUTIONS Perfortion Following Colorectl Endoscopy: Wht Hppens Beyond the Endoscopy Suite? Michel S Tm, MD; Mher A Abbs, MD, FACS, FASCRS
More informationOne of the most important biological mechanisms of
Brief Report Serum Thymidine Kinse 1 Activity in the Prognosis nd Monitoring of Chemotherpy in Lung Cncer Ptients: A Brief Report Benjmin Nismn, PhD,* Hovv Nechushtn, MD, PhD,* Him Birn, MD, Hds Gntz-Sorotsky,
More informationA retrospective, single center cohort study on 65 patients with primary retroperitoneal liposarcoma
ONCOLOGY LETTERS 15: 1799-1810, 2018 A retrospective, single center cohort study on 65 ptients with primry retroperitonel liposrcom YI XI WU 1, JUN YAN LIU 1*, JIA JIA LIU 1*, PENG YAN 1, BO TANG 1, YOU
More informationSignificance of Expression of TGF- in Pulmonary Metastasis in Non-small Cell Lung Cancer Tissues
Originl Article Significnce of Expression of in Pulmonry Metstsis in Non-smll Cell Lung Cncer Tissues Hisshi Sji, Hruhiko Nkmur, Idiris Awut, Norihito Kwski, Msru Hgiwr, Akihiko Ogt, Mkoto Hosk, Tkmoto
More informationRecall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study
Syddnsk Universitet Recll Bis in Childhood Atopic Diseses Among Adults in The Odense Adolescence Cohort Study Mørtz, Chrlotte G; Andersen, Klus Ejner; Bindslev-Jensen, Crsten Published in: Act Dermto-Venereologic
More informationR Martino 1, P Romero 1, M Subirá 1, M Bellido 1, A Altés 1, A Sureda 1, S Brunet 1, I Badell 2, J Cubells 2 and J Sierra 1
Bone Mrrow Trnsplnttion, (1999) 24, 283 287 1999 Stockton Press All rights reserved 0268 3369/99 $12.00 http://www.stockton-press.co.uk/bmt Comprison of the clssic Glucksberg criteri nd the IBMTR Severity
More information27 June Bmnly L. WALTER ET AL.: RESPONSE OF CERVICAL CANCERS TO IRRADIATION
27 June 1964 Bmnly MEDICAL JOURNAL L. WALTER ET AL.: RESPONSE OF CERVICAL CANCERS TO IRRADIATION x 1,638.) FIG. 2.-Foci of sme tumour s in Fig. 1 contining vible tumour cells with scnty cytoplsm, reltively
More informationBMI and Mortality: Results From a National Longitudinal Study of Canadian Adults
nture publishing group BMI nd Mortlity: Results From Ntionl Longitudinl Study of Cndin Adults Hether M. Orpn 1, Jen-Mrie Berthelot 2,3, Mrk S. Kpln 4, Dvid H. Feeny 5,6, Bentson McFrlnd 7 nd Nncy A. Ross
More informationCHEST. Thyroid transcription factor 1 (TTF-1) is an important. Original Research
CHEST Originl Reserch Clinicl Significnce of Thyroid Trnscription Fctor-1 in Advnced Lung Adenocrcinom Under Epiderml Growth Fctor Receptor Tyrosine Kinse Inhibitor Tretment Kuei-Pin Chung, MD; Yen-Tsung
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationUsing proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience
ORIGINAL ARTICLE Using prolifertive mrkers nd Oncotype DX in therpeutic decision-mking for brest cncer: the B.C. experience E. Bxter bsc,* L. Gondr btech pdc, C. Lohrisch md, S. Chi md, K. Gelmon md, M.
More informationLATE RESULTS OF TRANSFER OF THE TIBIAL TUBERCLE FOR RECURRENT DISLOCATION OF THE PATELLA1
LATE RESULTS OF TRANSFER OF THE TIBIAL TUBERCLE FOR RECURRENT DISLOCATION OF THE PATELLA1 W. G. J. HAMPSON nd P. HILL, BRISTOL, ENGLAND The uthors wished to determine the lte results of the Huser opertion,
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationBiliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan
J Heptoiliry Pncret Surg (2009) 16:1 7 DOI 10.1007/s00534-008-0015-0 TOPICS Biliry trct cncer sttistics registry in Jpn Biliry trct cncer tretment: 5,584 results from the Biliry Trct Cncer Sttistics Registry
More informationAnalysis of Risk Factors for the Development of Incisional and Parastomal Hernias in Patients after Colorectal Surgery
Originl Article Journl of the Koren Society of J Koren Soc Coloproctol 2012;28(6):299-303 http://dx.doi.org/10.3393/jksc.2012.28.6.299 pissn 2093-7822 eissn 2093-7830 Anlysis of Risk Fctors for the Development
More informationSponsor / Company: Sanofi Drug substance(s): AVE0005 (aflibercept)
These results re supplied for informtionl purposes only. Prescribing decisions should be mde bsed on the pproved pckge insert in the country of prescription. Sponsor / Compny: Snofi Drug substnce(s): AVE0005
More informationImmune-Mediated Adverse Reactions Management Guide
Immune-Medited Adverse Rections Mngement Guide INDICATIONS AND USAGE YERVOY (ipilimumb) is indicted for: Tretment of unresectble or metsttic melnom in dults nd peditric ptients (12 yers nd older) Adjuvnt
More informationEuropean Journal of Internal Medicine
Europen Journl of Internl Medicine 22 (2011) 399 406 Contents lists vilble t ScienceDirect Europen Journl of Internl Medicine journl homepge: www.elsevier.com/locte/ejim Originl rticle Incidence of cute
More informationRheumatoid-susceptible alleles of HLA-DRB 1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists
Annls of the Rheumtic Diseses 1994; 53: 587-592 587 Deprtment of Orthopedic Surgery, Knsi Medicl University, Otokoym Hospitl, Kyoto, Jpn Y Tod Y Mori Deprtment of Orthopedic Surgery, Knsi Medicl University,
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationORIGINAL ARTICLE ABSTRACT INTRODUCTION
ORIGINAL ARTICLE LOSS OF EPCAM STAINING CORRELATES WITH POOR OUTCOME IN CRC, Wng et l. Reduction in membrnous immunohistochemicl stining for the intrcellulr domin of epithelil cell dhesion molecule correltes
More informationClinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin
DOI:10.1111/hpb.12193 HPB ORIGINAL ARTICLE Clinicopthologicl nlysis nd prognosis of extrheptic bile duct cncer with microscopic positive ductl mrgin In Woong Hn 1 *, Jin-Young Jng 2 *, Kyoung Bun Lee 3,
More informationSingle-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA
Single-Molecule Studies of Unlbelled Full-Length p53 Protein Binding to DNA Philipp Nuttll, 1 Kidn Lee, 2 Pietro Ciccrell, 3 Mrco Crminti, 3 Giorgio Ferrri, 3 Ki- Bum Kim, 2 Tim Albrecht 1* 1 Imperil College
More informationRadiation therapy (RT) for cancer that involves the thorax
Originl Article Prospective Explortory Anlysis of Crdic Biomrkers nd Electrocrdiogrm Abnormlities in Ptients Receiving Thorcic Rdition Therpy with High-Dose Hert Exposure Dniel R. Gomez, MD,* Syed Wmique
More informationPrognostic factors in tongue cancer relative importance of demographic, clinical and histopathological factors
British Journl of Cncer (2000) 83(5), 614 619 doi: 10.1054/ bjoc.2000.1323, vilble online t http://www.idelibrry.com on Prognostic fctors in tongue cncer reltive importnce of demogrphic, clinicl nd histopthologicl
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationClinical statistics analysis on the characteristics of pneumoconiosis of Chinese miner population
Originl Article Clinicl sttistics nlysis on the chrcteristics of pneumoconiosis of Chinese miner popultion Mei-Fng Wng 1 *, Run-Ze Li 2 *, Ying Li 2, Xue-Qin Cheng 1, Jun Yng 1, Wen Chen 3, Xing-Xing Fn
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationEffect of Preoperative Intravenous Methocarbamol and Intravenous Acetaminophen on Opioid Use After Primary Total Hip and Knee Replacement
Feture Article Effect of Preopertive Intrvenous Methocrbmol nd Intrvenous Acetminophen on Opioid Use After Primry Totl Hip nd Knee Replcement THOMAS D. LOOKE, MD, PHD; CAMERON T. KLUTH, MBA bstrct Between
More informationAcademia Pharma Intersect: Lung Cancer. A. JOHN IAFRATE c
The Oncologist Acdemi Phrm Intersect: Lung Cncer Crizotinib for the Tretment of ALK-Rerrnged Non-Smll Cell Lung Cncer: A Success Story to Usher in the Second Decde of Moleculr Trgeted Therpy in Oncology
More informationNeutrophil lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
2454 Neutrophil lymphocyte rtio predicts survivl in pncretic neuroendocrine tumors GUOPEI LUO 1 3*, CHEN LIU 1 3*, HE CHENG 1 3*, KAIZHOU JIN 1 3, MENG GUO 1 3, YU LU 1 3, JIANG LONG 1 3, JIN XU 1 3, QUANXING
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationSystematic review of actual 10-year survival following resection for hepatocellular carcinoma
DOI:10.1111/j.1477-2574.2012.00446.x HPB SYSTEMATIC REVIEW Systemtic review of ctul 10-yer survivl following resection for heptocellulr crcinom Annelise M. Gluer 1, Nichols Cocco 1, Jerome M. Lurence 1,2,
More informationMortality of patients with multiple sclerosis: a cohort study in UK primary care
Mortlity of ptients with multiple sclerosis: cohort study in UK primry cre The Hrvrd community hs mde this rticle openly vilble. Plese shre how this ccess benefits you. Your story mtters Cittion Jick,
More informationStudies of the Mortality of Atomic Bomb Survivors, Report 14, : An Overview of Cancer and Noncancer Diseases
RADIATION RESEARCH 177, 229 243 (2012) 0033-7587/12 $15.00 Ó2012 by Rdition Reserch Society. All rights of reproduction in ny form reserved. DOI: 10.1667/RR2629.1 Studies of the Mortlity of Atomic Bomb
More informationFor Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)
For Adults With Previously Treted Advnced Non-Smll Cell Lung Cncer (NSCLC) individuls depicted re models used for illustrtive purposes only. It cn be overwhelming to lern tht your previously treted dvnced
More informationOsteosarcoma: A Meta-Analysis and Review of the Literature
A Review Pper Osteosrcom: A Met-Anlysis nd Review of the Literture Jill C. Friebele, MD, Jeffrey Peck, MD, Xueling Pn, PhD, Mhmoud Abdel-Rsoul, MS, MPH, nd Joel L. Myerson, MD Abstrct Over the pst 30 yers,
More informationT max (hr) 1.5 ± ± ± 0.6 AUC (0-10) (ng hr/ml)
Progesterone Cpsules (progesterone, USP), 100 mg nd 200 mg WARNING: CARDIOVASCULAR DISORDERS, BREAST CANCER nd PROBABLE DEMENTIA FOR ESTROGEN PLUS PROGESTIN THERAPY Crdiovsculr Disorders nd Probble Dementi
More informationOsteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes
ONCOLOGY LETTERS Osteosrcom in ptients below 25 yers of ge: An observtionl study of incidence, metstsis, tretment nd outcomes ZHIGANG NIE nd HAO PENG Deprtment of Orthopedics, Renmin Hospitl of Wuhn University,
More informationPredictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy
The Americn Society of Gene & Cell Therpy originl rticle Predictive nd Prognostic Clinicl Vribles in Cncer Ptients Treted With Adenovirl Oncolytic Immunotherpy Kristin Tiple 1, Ilkk Liiknen 1, Anniin Koski
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationBreast carcinoma grading by histologic features has
Originl Articles Mitotic Index of Invsive Brest Crcinom Achieving Cliniclly Meningful Precision nd Evluting Tertil Cutoffs John S. Meyer, MD; Eric Costto, PhD; Hns Peter Grf, PhD Context. Mitotic figure
More informationYERVOY (ipilimumab) injection, for intravenous use Initial U.S. Approval: 2011
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use sfely nd effectively. See full prescribing informtion for. (ipilimumb) injection, for intrvenous use
More informationUS Food and Drug Administration-Mandated Trials of Long-Acting b -Agonists Safety in Asthma. Samy Suissa, PhD ; and Amnon Ariel, MD, FCCP
CHEST Commentry US Food nd Drug Administrtion-Mndted Trils of Long-Acting b -Agonists Sfety in Asthm Will We Know the Answer? Smy Suiss, PhD ; nd Amnon Ariel, MD, FCCP For 2 decdes, long-cting b -gonists
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationC reactive protein: an aid to assessment and
C rective protein: n id to ssessment nd monitoring of cute pncretitis J Clin Pthol 1984;37:27-211 AD MAYR,* MJ McMAHON,* MARGART BOWN,t H COOPRt From the *University Deprtment ofsurgery, Generl Infrmry,
More information